Global Cancer Biological Therapy Market Size, Share, Growth Analysis Report - Forecast 2034

Cancer Biological Therapy Market

Cancer Biological Therapy Market By Type (Monoclonal Antibodies, Vaccines, Cancer Growth Blockers, Cytokines, Gene Therapy, Others), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034

Category: Biotechnology Report Format : PDF Pages: 225 Report Code: ZMR-3862 Published Date: Jun-2025 Status : Published
Market Size in 2024 Market Forecast in 2034 CAGR (in %) Base Year
USD 11.52 Billion USD 24.87 Billion 8% 2024

Cancer Biological Therapy Market

Request Free Sample

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Cancer Biological Therapy Market, (2023 - 2030) (USD Billion)
    • 2.2 Global Cancer Biological Therapy Market : snapshot
  • Chapter 3. Global Cancer Biological Therapy Market - Industry Analysis
    • 3.1 Cancer Biological Therapy Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 The surge in cancer occurrence to boost the global market demand across the globe over 2023-2030
    • 3.3 Market Restraints
      • 3.3.1. Side effects of treatment in patients can prove detrimental to the global industry expansion
    • 3.4 Market Opportunities
      • 3.4.1. Rise in fundraising and investments for developing innovative cancer treatment modes to open new growth avenues for the global market
    • 3.5 Market Challenges
      • 3.5.1. Huge treatment costs and low availability of professionals can put up a huge challenge in the growth path of the industry across the globe
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Application
      • 3.7.2 Market attractiveness analysis By Product Type
  • Chapter 4. Global Cancer Biological Therapy Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Cancer Biological Therapy Market: company market share, 2022
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Cancer Biological Therapy Market - Application Analysis
    • 5.1 Global Cancer Biological Therapy Market overview: By Application
      • 5.1.1 Global Cancer Biological Therapy Market share, By Application , 2022 and 2030
    • 5.2 Diagnostic Laboratories
      • 5.2.1 Global Cancer Biological Therapy Market by Diagnostic Laboratories, 2023 - 2030 (USD Billion)
    • 5.3 Hospitals
      • 5.3.1 Global Cancer Biological Therapy Market by Hospitals, 2023 - 2030 (USD Billion)
    • 5.4 Pharmaceutical & Biotechnology Companies
      • 5.4.1 Global Cancer Biological Therapy Market by Pharmaceutical & Biotechnology Companies, 2023 - 2030 (USD Billion)
    • 5.5 Research & Academic Laboratories
      • 5.5.1 Global Cancer Biological Therapy Market by Research & Academic Laboratories, 2023 - 2030 (USD Billion)
  • Chapter 6. Global Cancer Biological Therapy Market - Product Type Analysis
    • 6.1 Global Cancer Biological Therapy Market overview: By Product Type
      • 6.1.1 Global Cancer Biological Therapy Market share, By Product Type, 2022 and 2030
    • 6.2 Monoclonal Antibodies
      • 6.2.1 Global Cancer Biological Therapy Market by Monoclonal Antibodies, 2023 - 2030 (USD Billion)
    • 6.3 Vaccines
      • 6.3.1 Global Cancer Biological Therapy Market by Vaccines, 2023 - 2030 (USD Billion)
    • 6.4 Cancer Growth Blockers
      • 6.4.1 Global Cancer Biological Therapy Market by Cancer Growth Blockers, 2023 - 2030 (USD Billion)
    • 6.5 Blood Cell Growth Factors
      • 6.5.1 Global Cancer Biological Therapy Market by Blood Cell Growth Factors, 2023 - 2030 (USD Billion)
    • 6.6 Cytokine
      • 6.6.1 Global Cancer Biological Therapy Market by Cytokine, 2023 - 2030 (USD Billion)
  • Chapter 7. Cancer Biological Therapy Market - Regional Analysis
    • 7.1 Global Cancer Biological Therapy Market Regional Overview
    • 7.2 Global Cancer Biological Therapy Market Share, by Region, 2022 & 2030 (USD Billion)
    • 7.3. North America
      • 7.3.1 North America Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
        • 7.3.1.1 North America Cancer Biological Therapy Market, by Country, 2023 - 2030 (USD Billion)
    • 7.4 North America Cancer Biological Therapy Market, by Application , 2023 - 2030
      • 7.4.1 North America Cancer Biological Therapy Market, by Application , 2023 - 2030 (USD Billion)
    • 7.5 North America Cancer Biological Therapy Market, by Product Type, 2023 - 2030
      • 7.5.1 North America Cancer Biological Therapy Market, by Product Type, 2023 - 2030 (USD Billion)
    • 7.4. Europe
      • 7.4.2 Europe Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
        • 7.4.2.1 Europe Cancer Biological Therapy Market, by Country, 2023 - 2030 (USD Billion)
    • 7.4 Europe Cancer Biological Therapy Market, by Application , 2023 - 2030
      • 7.4.1 Europe Cancer Biological Therapy Market, by Application , 2023 - 2030 (USD Billion)
    • 7.5 Europe Cancer Biological Therapy Market, by Product Type, 2023 - 2030
      • 7.5.1 Europe Cancer Biological Therapy Market, by Product Type, 2023 - 2030 (USD Billion)
    • 7.5. Asia Pacific
      • 7.5.3 Asia Pacific Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
        • 7.5.3.1 Asia Pacific Cancer Biological Therapy Market, by Country, 2023 - 2030 (USD Billion)
    • 7.4 Asia Pacific Cancer Biological Therapy Market, by Application , 2023 - 2030
      • 7.4.1 Asia Pacific Cancer Biological Therapy Market, by Application , 2023 - 2030 (USD Billion)
    • 7.5 Asia Pacific Cancer Biological Therapy Market, by Product Type, 2023 - 2030
      • 7.5.1 Asia Pacific Cancer Biological Therapy Market, by Product Type, 2023 - 2030 (USD Billion)
    • 7.6. Latin America
      • 7.6.4 Latin America Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
        • 7.6.4.1 Latin America Cancer Biological Therapy Market, by Country, 2023 - 2030 (USD Billion)
    • 7.4 Latin America Cancer Biological Therapy Market, by Application , 2023 - 2030
      • 7.4.1 Latin America Cancer Biological Therapy Market, by Application , 2023 - 2030 (USD Billion)
    • 7.5 Latin America Cancer Biological Therapy Market, by Product Type, 2023 - 2030
      • 7.5.1 Latin America Cancer Biological Therapy Market, by Product Type, 2023 - 2030 (USD Billion)
    • 7.7. The Middle-East and Africa
      • 7.7.5 The Middle-East and Africa Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
        • 7.7.5.1 The Middle-East and Africa Cancer Biological Therapy Market, by Country, 2023 - 2030 (USD Billion)
    • 7.4 The Middle-East and Africa Cancer Biological Therapy Market, by Application , 2023 - 2030
      • 7.4.1 The Middle-East and Africa Cancer Biological Therapy Market, by Application , 2023 - 2030 (USD Billion)
    • 7.5 The Middle-East and Africa Cancer Biological Therapy Market, by Product Type, 2023 - 2030
      • 7.5.1 The Middle-East and Africa Cancer Biological Therapy Market, by Product Type, 2023 - 2030 (USD Billion)
  • Chapter 8. Company Profiles
    • 8.1 Bristol-Myers Squibb
      • 8.1.1 Overview
      • 8.1.2 Financials
      • 8.1.3 Product Portfolio
      • 8.1.4 Business Strategy
      • 8.1.5 Recent Developments
    • 8.2 Spectrum Pharmaceuticals
      • 8.2.1 Overview
      • 8.2.2 Financials
      • 8.2.3 Product Portfolio
      • 8.2.4 Business Strategy
      • 8.2.5 Recent Developments
    • 8.3 Amgen
      • 8.3.1 Overview
      • 8.3.2 Financials
      • 8.3.3 Product Portfolio
      • 8.3.4 Business Strategy
      • 8.3.5 Recent Developments
    • 8.4 F. Hoffmann-La Roche
      • 8.4.1 Overview
      • 8.4.2 Financials
      • 8.4.3 Product Portfolio
      • 8.4.4 Business Strategy
      • 8.4.5 Recent Developments
    • 8.5 AbbVie
      • 8.5.1 Overview
      • 8.5.2 Financials
      • 8.5.3 Product Portfolio
      • 8.5.4 Business Strategy
      • 8.5.5 Recent Developments
    • 8.6 AstraZeneca
      • 8.6.1 Overview
      • 8.6.2 Financials
      • 8.6.3 Product Portfolio
      • 8.6.4 Business Strategy
      • 8.6.5 Recent Developments
    • 8.7 Novartis AG
      • 8.7.1 Overview
      • 8.7.2 Financials
      • 8.7.3 Product Portfolio
      • 8.7.4 Business Strategy
      • 8.7.5 Recent Developments
    • 8.8 Astellas
      • 8.8.1 Overview
      • 8.8.2 Financials
      • 8.8.3 Product Portfolio
      • 8.8.4 Business Strategy
      • 8.8.5 Recent Developments
    • 8.9 Pfizer
      • 8.9.1 Overview
      • 8.9.2 Financials
      • 8.9.3 Product Portfolio
      • 8.9.4 Business Strategy
      • 8.9.5 Recent Developments
    • 8.10 Celgene Corporation
      • 8.10.1 Overview
      • 8.10.2 Financials
      • 8.10.3 Product Portfolio
      • 8.10.4 Business Strategy
      • 8.10.5 Recent Developments
    • 8.11 Sanofi
      • 8.11.1 Overview
      • 8.11.2 Financials
      • 8.11.3 Product Portfolio
      • 8.11.4 Business Strategy
      • 8.11.5 Recent Developments
    • 8.12 Takeda Pharmaceuticals
      • 8.12.1 Overview
      • 8.12.2 Financials
      • 8.12.3 Product Portfolio
      • 8.12.4 Business Strategy
      • 8.12.5 Recent Developments
    • 8.13 Bayer
      • 8.13.1 Overview
      • 8.13.2 Financials
      • 8.13.3 Product Portfolio
      • 8.13.4 Business Strategy
      • 8.13.5 Recent Developments
    • 8.14 ELI Lilly & Company
      • 8.14.1 Overview
      • 8.14.2 Financials
      • 8.14.3 Product Portfolio
      • 8.14.4 Business Strategy
      • 8.14.5 Recent Developments
    • 8.15 Eisai
      • 8.15.1 Overview
      • 8.15.2 Financials
      • 8.15.3 Product Portfolio
      • 8.15.4 Business Strategy
      • 8.15.5 Recent Developments
    • 8.16 GlaxoSmithKline
      • 8.16.1 Overview
      • 8.16.2 Financials
      • 8.16.3 Product Portfolio
      • 8.16.4 Business Strategy
      • 8.16.5 Recent Developments
    • 8.17 Merck
      • 8.17.1 Overview
      • 8.17.2 Financials
      • 8.17.3 Product Portfolio
      • 8.17.4 Business Strategy
      • 8.17.5 Recent Developments
    • 8.18 Incyte
      • 8.18.1 Overview
      • 8.18.2 Financials
      • 8.18.3 Product Portfolio
      • 8.18.4 Business Strategy
      • 8.18.5 Recent Developments
    • 8.19 Otsuka
      • 8.19.1 Overview
      • 8.19.2 Financials
      • 8.19.3 Product Portfolio
      • 8.19.4 Business Strategy
      • 8.19.5 Recent Developments
    • 8.20 and Seattle Genetics.
      • 8.20.1 Overview
      • 8.20.2 Financials
      • 8.20.3 Product Portfolio
      • 8.20.4 Business Strategy
      • 8.20.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Cancer Biological Therapy Market attractiveness, By Application
  • 6. Global Cancer Biological Therapy Market attractiveness, By Product Type
  • 7. Global Cancer Biological Therapy Market share by Application , 2023 and 2030 (USD Billion)
  • 8. Global Cancer Biological Therapy Market by Diagnostic Laboratories, 2023 - 2030 (USD Billion)
  • 9. Global Cancer Biological Therapy Market by Hospitals, 2023 - 2030 (USD Billion)
  • 10. Global Cancer Biological Therapy Market by Pharmaceutical & Biotechnology Companies, 2023 - 2030 (USD Billion)
  • 11. Global Cancer Biological Therapy Market by Research & Academic Laboratories, 2023 - 2030 (USD Billion)
  • 12. Global Cancer Biological Therapy Market share by Product Type, 2023 and 2030 (USD Billion)
  • 13. Global Cancer Biological Therapy Market by Monoclonal Antibodies, 2023 - 2030 (USD Billion)
  • 14. Global Cancer Biological Therapy Market by Vaccines, 2023 - 2030 (USD Billion)
  • 15. Global Cancer Biological Therapy Market by Cancer Growth Blockers, 2023 - 2030 (USD Billion)
  • 16. Global Cancer Biological Therapy Market by Blood Cell Growth Factors, 2023 - 2030 (USD Billion)
  • 17. Global Cancer Biological Therapy Market by Cytokine, 2023 - 2030 (USD Billion)
  • 18. Global Cancer Biological Therapy Market share, by Region, 2023 and 2030
  • 19. North America Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
  • 20. Europe Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
  • 21. Asia Pacific Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
  • 22. Latin America Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)
  • 23. The Middle-East and Africa Cancer Biological Therapy Market, 2023 - 2030 (USD Billion)

Table Of Tables

  • 1. Global Cancer Biological Therapy Market: Snapshot
  • 2. Drivers of the Cancer Biological Therapy Market: impact analysis
  • 3. North America Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 4. North America Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 5. U.S. Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 6. U.S. Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 7. Canada Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 8. Canada Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 9. Europe Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 10. Europe Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 11. Germany Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 12. Germany Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 13. France Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 14. France Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 15. U.K. Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 16. U.K. Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 17. Italy Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 18. Italy Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 19. Spain Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 20. Spain Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 21. Rest of Europe Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 22. Rest of Europe Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 23. Asia Pacific Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 24. Asia Pacific Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 25. China Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 26. China Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 27. Japan Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 28. Japan Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 29. India Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 30. India Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 31. South Korea Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 32. South Korea Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 33. South-East Asia Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 34. South-East Asia Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 35. Rest of Asia Pacific Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 36. Rest of Asia Pacific Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 37. Latin America Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 38. Latin America Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 39. Brazil Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 40. Brazil Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 41. Mexico Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 42. Mexico Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 43. Rest of Latin America Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 44. Rest of Latin America Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 45. The Middle-East and Africa Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 46. The Middle-East and Africa Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 47. GCC Countries Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 48. GCC Countries Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 49. South Africa Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 50. South Africa Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)
  • 51. Rest of Middle-East Africa Cancer Biological Therapy Market revenue, By Application , 2023 - 2030 (USD Billion)
  • 52. Rest of Middle-East Africa Cancer Biological Therapy Market revenue, By Product Type, 2023 - 2030 (USD Billion)

Methodology

FrequentlyAsked Questions

The global cancer biological therapy market is expected to grow due to Increasing cancer prevalence and shift towards targeted, less toxic treatments drive demand. Biotech innovations and personalized medicine approaches support market growth.

According to a study, the global cancer biological therapy market size was worth around USD 11.52 Billion in 2024 and is expected to reach USD 24.87 Billion by 2034.

The global cancer biological therapy market is expected to grow at a CAGR of 8% during the forecast period.

North America is expected to dominate the cancer biological therapy market over the forecast period.

Leading players in the global cancer biological therapy market include Bristol-Myers Squibb, Spectrum Pharmaceuticals, Amgen, F. Hoffmann-La Roche, AbbVie, AstraZeneca, Novartis AG, Astellas, Pfizer, Celgene Corporation, Sanofi, Takeda Pharmaceuticals, Bayer, ELI Lilly & Company, Eisai, GlaxoSmithKline, Merck, Incyte, Otsuka, and Seattle Genetics., among others.

The report explores crucial aspects of the cancer biological therapy market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.

  • zion payment modes

List of Contents

Industry PerspectiveOverviewKey InsightsGrowth FactorsRestraintsOpportunitiesChallengesSegmentationReport ScopeRegional InsightsCompetitive AnalysisThe global cancer biological therapy market is segmented as follows;

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed